Naohisa Tomosugi - Concepedia

Author

Naohisa Tomosugi

Also Known As

Mitsumasa Ohyanagi, N I Tomosugi, N Tomosugi, N. Tomosugi, NAOHISA TOMOSUGI, Naohisa TOMOSUGI, Naohisa Tomosugi, Yoshihiko Saito

153

Publications

5.2K

Citations

H-Index

140

Concepts

All Affiliations

Kanazawa Medical University Kanazawa University Kyoto University The University of Osaka Nagoya University

About

Naohisa Tomosugi is an author at Kanazawa Medical University specializing in medicine, pathology, and glomerulonephritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	34	2.4K
2	Allergy	3	3	860
3	Health Sciences	2	2	50
4	Natural Sciences	2	2	105
5	Engineering	1	1	16

Naohisa Tomosugi

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki, Modern Rheumatology General ConceptImmunodeficienciesImmunologyPathologyImmunotherapy	2012	683
Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata, Blood	2010	224
Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. Naohisa Tomosugi, S. J. Cashman, Hay H, The Journal of Immunology Glomerular DiseaseRenal PathologyImmunologyRenal InflammationPathology	1989	182
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization Joyce JC Kroot, Erwin Kemna, Sukhvinder S. Bansal, Haematologica Iron MetabolismHormone HepcidinMetabolomic ProfilingBioanalysisAnalytical Chemistry	2009	178
Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis Takashi Wada, Kengo Furuichi, Norihiko Sakai, Journal of the American Society of Nephrology	2004	172
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients Soken-Nakazawa J. Song, Mitsuhiro Iwahashi, Naohisa Tomosugi, Arthritis Research & Therapy	2013	136
Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. Takashi Wada, Naohisa Tomosugi, Tatsushi Naito, The Journal of Experimental Medicine Glomerular DiseaseRenal PathologyImmunologyRenal InflammationPathology	1994	131
Detection of urinary interleukin-8 in glomerular diseases Takashi Wada, Hitoshi Yokoyama, Naohisa Tomosugi, Kidney International Glomerular DiseaseGlomerulonephritisUrologyUrinary Interleukin-8Renal Function	1994	117
Gene Therapy Expressing Amino-Terminal Truncated Monocyte Chemoattractant Protein-1 Prevents Renal Ischemia-Reperfusion Injury Kengo Furuichi, Takashi Wada, Yasunori Iwata, Journal of the American Society of Nephrology	2003	100
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion Naoki Fujita, Ryosuke Sugimoto, Satoshi Motonishi, Journal of Hepatology HepatologyHepatitis CHepcidin SecretionViral HepatitisAntiviral Therapy	2008	85

Page 1